Biggest news of relief for India in good news / epidemic, ICMR claim raises hope after research.
Amid concerns over the corona virus, there has been some relief on vaccination.
Important claim regarding covacin vaccine
Also working on Corona's double mutant: ICMR
Also working on variants from UK, Brazil and Africa
The growing corona speed in the country has caused outcry. Amidst all these worries some relieving news on vaccination has come to the fore as hospital beds in different parts of the country have become housefull. An ICMR study claims that Covex corona of Bharat Biotech has been shown to be effective on several mutants.
At a time when cases of corona virus are on the rise in the country and record-breaking cases are coming up every day, on the other hand, the world's largest vaccination campaign against corona virus is being carried out in the country, ICMR research has revealed.
Vaccination against corona virus in India was started in January as a ray of hope. That's when the big news came about the vaccine issue. Research by ICMR claims that the native vaccine covacin of the corona virus is effective on most variants.
ICMR research claims that covacin can fight different variants of the corona virus. Most importantly, covexin is also very effective in fighting the double mutant strain of Corona virus. It is to be noted that Covexin is an indigenous vaccine of India and is manufactured by India Biotech. According to an ICMR study, the vaccine is effective in beating the UK, Brazilian and African variants of the Corona. Not only that, covexin also eliminates the risk of double mutants.
Importantly, many of Corona's mutants are currently active in India. Many cases involving UK, Brazil and African strains have already been found in India. It was recently learned that desi variants have also been made in India with the highest number of cases being found in Bengal. The new ICMR study has brought a ray of hope.
